Novel Approaches to CRISPR Gene Editing in Cancer Treatment

Manuscript ID: MS-2023-0042

Under Review

Submission Details

Journal

Nature Biotechnology

Submitted On

July 12, 2023

Current Version

v2.0 (Revised on Aug 5, 2023)

Author Information

Corresponding Author

Dr. Michael Chen

Co-Authors

Dr. Sarah Johnson, Dr. Robert Lee

Institution

Stanford University Medical Center

Review Information

Editor Assigned

Dr. Emily Rodriguez

Reviewers Assigned

3 of 3 Confirmed

Expected Decision Date

September 30, 2023

Progress Timeline

Initial Submission

Completed

July 12, 2023 at 10:25 AM

Manuscript submitted to Nature Biotechnology with all required documents and metadata.

Initial Technical Check

Completed

July 14, 2023 at 3:45 PM

Technical review passed. Manuscript meets journal formatting requirements.

Editor Assignment

Completed

July 18, 2023 at 11:10 AM

Dr. Emily Rodriguez assigned as handling editor for your manuscript.

Editor Initial Decision

Completed

July 21, 2023 at 2:30 PM

Editor has decided to send your manuscript for peer review.

Reviewer Assignment

Completed

July 28, 2023 at 9:15 AM

3 reviewers have been invited and all have accepted to review your manuscript.

Peer Review in Progress

In Progress

Started July 29, 2023

Reviewers are currently evaluating your manuscript. 2 of 3 reviews have been submitted.

66%

Editorial Decision

Pending

Expected by September 15, 2023

The editor will make a decision based on the reviewer recommendations.

Revision

Pending

Not yet scheduled

If requested, you will need to submit a revised manuscript addressing reviewer comments.

Final Decision

Pending

Expected by September 30, 2023

Final decision on your manuscript will be made after reviewing all materials.

Review Status

R1

Reviewer #1

Expert in CRISPR Technology

Completed Aug 15, 2023
R2

Reviewer #2

Cancer Research Specialist

Completed Aug 21, 2023
R3

Reviewer #3

Molecular Biology Expert

In Progress Due Sep 5, 2023

Review Type

Double-blind peer review (Author and reviewer identities concealed)

Review Timeline Statistics

Average Review Time

24 days

Journal average: 28 days

Expected Decision

30 days

From submission to decision

Communication History

Editor

Dr. Emily Rodriguez (Editor)

Aug 5, 2023 at 10:15 AM

Editor Message

Dear Dr. Chen,

Thank you for submitting your revised manuscript. We have sent it to the reviewers for evaluation. You will be notified once all reviews have been received and a decision has been made.

Best regards,
Dr. Emily Rodriguez

Author

Dr. Michael Chen (You)

Aug 5, 2023 at 9:30 AM

Revision Submitted

Dear Dr. Rodriguez,

I have submitted the revised version of our manuscript addressing the initial technical concerns. The revised manuscript includes updated figures and supplementary materials as requested.

Sincerely,
Dr. Michael Chen

Editor

Dr. Emily Rodriguez (Editor)

Jul 29, 2023 at 2:45 PM

Editor Message

Dear Dr. Chen,

Thank you for your submission to Nature Biotechnology. After initial review, we would like to request minor technical revisions before sending your manuscript to peer reviewers. Please address the following points:

  • Update Figure 2 resolution to meet journal standards (min 300 dpi)
  • Provide raw data for the gene expression analysis
  • Include additional supplementary materials as discussed

Best regards,
Dr. Emily Rodriguez